FDA Guidance on CT Mgmt during COVID-19

Health Care, Pharma Industry, Strategic Planning

FDA issued this guidance to provide general considerations to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 pandemic.

Read the Guidance now

Related Education Resources.

All Resources

Preparing for the Post-Brexit Clinical Supply Chain

Topics: Pharma Industry, Regulatory

Position Paper

Free

EAP 105: Expanded Access Logistics

Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning

Presentation

Members

Countdown to Brexit: Can your clinical supply chain pass the Brexit pressure test

Topics: Pharma Industry, Politics

White Paper

Members

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.

Join Renew